Investors / South Korea / ActnerLab
ActnerLab
Accelerator · Seoul, South Korea · Asia Pacific
ActnerLab is a Seoul-based global accelerator that provides seed funding, mentorship, and access to government grants such as the TIPS program. It also operates Cheongna Science Park, a campus with hubs for biomedical research, STEAM education, academic partnership, and a social district.
Invests inHealthcare & Biotech
In its own wordsdeep techdigital healthcarebiotechmedtechphysical aiai
Your fit with ActnerLab
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsActnerLab lists 21 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (64%), Robotics & Hardware (8%) and Fintech (8%). 90% of its companies are based in South Korea. It invests most often alongside CITRIS Foundry, Dayli Partners and InterVest.
No funding round on record names ActnerLab yet, so the figures come from its portfolio page.
Round figures show recent activity, not ActnerLab's whole history. Rounds on record name 0 companies; its own site lists 21. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 64% | 15% |
| Robotics & Hardware | 8% | 1% |
| Fintech | 8% | 12% |
| Industrial & Manufacturing | 8% | 7% |
| Cybersecurity | 4% | 4% |
| Enterprise Software | 4% | 8% |
| AI & Machine Learning | 4% | 18% |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2095%
- No longer answers00%
- Points to another company15%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 53th | 21 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 90th | 64% in its largest sector |
| Reach | 58th | 3 countries |
Co-investor network
who it backs companies with, and who they back togetherCompare ActnerLab head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
21 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| BioBankHealing develops and supplies FMT treatment solutions and next-generation microbiome therapies | Healthcare & Biotech | Portfolio page | ||
| The company provides solutions for non-contact biometric measurement and computer system validation | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| The company provides contract development and manufacturing services for biopharmaceuticals, including vaccines and gene therapy products. | Healthcare & Biotech | Portfolio page | ||
| Dot Inc. develops and manufactures tactile Braille displays and other technology to improve accessibility for the visually impaired. | Healthcare & BiotechRobotics & Hardware | Portfolio page | ||
| The company develops and produces medical devices, such as wearable insulin pumps, to improve the quality of life for people with diseases or disabilities. | Healthcare & Biotech | Portfolio page | ||
| FEAGLE develops and sells plasma devices and cosmetic products | Healthcare & Biotech | Portfolio page | ||
| The company develops and commercializes products based on the gfCas12a gene editing technology for various applications, including research, diagnostics, and therapeutics. | Healthcare & Biotech | Portfolio page | ||
| The company designs and develops useful animals for pharmaceutical development and provides solutions to the biopharmaceutical industry. | Healthcare & Biotech | Portfolio page | ||
| Ghostpass provides biometric authentication solutions for various services, including access control, payment, and identity verification. | CybersecurityFintech | Portfolio page | ||
Fintech | Portfolio page | |||
| The company provides a SaaS platform for manufacturing data exchange and Catena-X solutions | Industrial & ManufacturingEnterprise Software | Portfolio page | ||
| L-BASE develops first-in-class drugs, including a cancer-specific autophagy inhibitor | Healthcare & Biotech | Portfolio page | ||
| Medihub develops and sells medical devices, including automatic injectors | Healthcare & Biotech | Portfolio page | ||
| The company develops biomaterials to address health issues associated with aging. | Healthcare & Biotech | Portfolio page | ||
| Meditulip develops and manufactures medical devices, including endoscopic linear staplers and chemoports. | Healthcare & Biotech | Portfolio page | ||
| Megnosis develops technologies for analyzing and improving cognitive functions, such as attention and memory, using EEG and reactive-EEG technology | Healthcare & Biotech | Portfolio page | ||
| MySmaX develops edge-based AI solutions for IoT and robotics management | AI & Machine LearningRobotics & Hardware | Portfolio page | ||
| Portfolio page | ||||
| Olive Healthcare innovates human health through technical innovation. | Healthcare & Biotech | Portfolio page | ||
| The company provides various solutions for clinical research, including data integration management and eCRF solutions. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- actnerlab.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 21
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get ActnerLab's profile as data
Pull ActnerLab's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/actnerlab.com
# also
GET /v1/firms/actnerlab.com/portfolio
GET /v1/firms/actnerlab.com/coinvestors
GET /v1/firms/actnerlab.com/news